-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Sionna Therapeutics with Buy Rating, Announces Price Target of $50

Benzinga·11/19/2025 10:14:09
Listen to the news
BTIG analyst Kambiz Yazdi initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Buy rating and announces Price Target of $50.